Clinical Research
Copyright ©The Author(s) 2004.
World J Gastroenterol. May 15, 2004; 10(10): 1513-1520
Published online May 15, 2004. doi: 10.3748/wjg.v10.i10.1513
Table 2 Effects of Kangshuanling sublingual tablet on CD62P and CD63, TXA2, platelet aggregation rate (PAR) and thrombosis length (TL) in vitro in UC patients (mean ± SD)
GroupCD62p (%)CD63 (%)TXA2 (ng/L)PAR (%)TL (cm)
UC patients
Pre-treatment8.0 ± 3.1b6.3 ± 2.1b548.2 ± 84.9b43.2 ± 10.1b2.3 ± 0.6b
Post-treatment4.1 ± 1.8a,d3.2 ± 1.6a,d390.1 ± 67.0d34.8 ± 8.1d1.8 ± 0.3d
Normal controls1.9 ± 0.41.6 ± 0.8340.2 ± 40.434.1 ± 9.11.7 ± 0.4